<DOC>
	<DOCNO>NCT02891447</DOCNO>
	<brief_summary>The goal clinical research study learn whether cytoreduction surgery ( surgery reduce remove lesion ) , gastrectomy ( part stomach remove ) , hyperthermic intraperitoneal chemoperfusion ( HIPEC , heat chemotherapy treatment deliver directly inside abdomen surgery ) help control disease patient gastric and/or gastroesophageal cancer . The safety procedure also study .</brief_summary>
	<brief_title>Study Cytoreduction , Gastrectomy , &amp; Hyperthermic Intraperitoneal Chemoperfusion ( HIPEC ) Gastric Adenocarcinoma Carcinomatosis Positive Cytology</brief_title>
	<detailed_description>Study Procedures : If participant eligible agree take part , follow procedure : - Standard-of-care cytoreduction surgery - Standard-of-care gastrectomy - HIPEC treatment surgery , participant receive mitomycin cisplatin 60 minute . HIPEC treatment mean participant receive mitomycin cisplatin 60 minute . Heated mitomycin cisplatin deliver plastic tubing connect pump abdominal cavity . The pump push heat mitomycin cisplatin abdominal cavity pull recirculates mitomycin cisplatin . The skin abdominal cavity temporarily close abdominal wash. A pump use pump heat mitomycin cisplatin abdominal cavity 60 minute surgeon gently press abdominal wall mitomycin cisplatin reach area abdominal cavity . After 60 minute , mitomycin cisplatin remove abdominal cavity wash . The remain fluid remove surgeon permanently close abdominal cavity stitch . - Participant also receive sodium thiosulfate help protect kidney low risk side effect cisplatin . Participant sign separate consent cytoreduction gastrectomy explain do risk involve . Length Study Participation : Patient 's active participation study surgery . Follow Up : Within 4 week participant 's surgery every 6 month , visit clinic call phone . Participant ask feel problem . If participant call , call last 5 minute . If study doctor think need , participant CT scan , MRI , positron emission tomography ( PET ) /CT scan abdomen , pelvis , and/or chest check status disease . This investigational study . Mitomycin cisplatin FDA-approved commercially available treatment gastric gastroesophageal cancer . The combination drug surgery investigational . Up 30 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Esophageal Diseases</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Sodium thiosulfate</mesh_term>
	<criteria>1 . Age 18 year . There upper age restriction . 2 . Eastern Cooperative Oncology Group ( ECOG ) performance status &lt; /= 2 . 3 . Cytologic histologic proof adenocarcinoma stomach gastroesophageal junction . 4 . Adequate renal , bone marrow function : a. Leukocytes &gt; = 3,000/uL b . Absolute neutrophil count &gt; = 1,500/uL c. Platelets &gt; = 60,000/Ul d. Serum creatinine &lt; = 1.5 mg/dL 5 . Distant metastatic disease peritoneum may visualize imaging : . Positive peritoneal cytology b. Carcinomatosis diagnostic laparoscopy laparotomy . 6 . Completion preoperative systemic chemotherapy preoperative laparoscopic HIPEC . 1 . Distant metastatic disease limit peritoneum : . Solid organ metastasis ( liver , central nervous system , lung ) . 2 . Infections pneumonia wound infection would preclude protocol therapy . 3 . Women positive urine serum pregnancy test exclude study ; woman childbearing potential ( define undergone hysterectomy postmenopausal least 24 consecutive month ) must agree refrain breast feed practice adequate contraception specify informed consent . Adequate contraception consist oral contraceptive , implantable contraceptive , injectable contraceptive , double barrier method , abstinence . 4 . Subjects unstable angina New York Heart Association Grade II great congestive heart failure . 5 . Subjects deem unable comply study and/or followup procedure . 6 . Subjects know hypersensitivity protocol systemic chemotherapy lifethreatening , require hospitalization prolongation exist hospitalization , result persistent significant disability incapacity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>